Autocallable Multi Barrier Reverse Convertible

Symbol: LBKODU
ISIN: CH1502673424
Issuer:
UBS
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Price Time-delayed price
23.06.26
17:33:23
- %
- %
USD
Volume
0
0
nominal
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 94.80
Diff. absolute / % 0.00 0.00%

Determined prices

Last Price 95.60 Volume 5,000
Time 10:14:48 Date 16/06/2026

More Product Information

Core Data

Name Autocallable Multi Barrier Reverse Convertible
ISIN CH1502673424
Valor 150267342
Symbol LBKODU
Quotation in percent Yes
Coupon p.a. 9.00%
Coupon Premium 5.45%
Coupon Yield 3.55%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
Exercise type American
Currency US Dollar
First Trading Date 04/12/2025
Date of maturity 06/12/2027
Last trading day 29/11/2027
Settlement Type Path-dependent
IRS 871m Potentially in scope for combined transactions
Currency safeguarded No
Pricing Dirty
Issuer UBS

Key data

Ask Price (basis for calculation) 95.4500
Maximum yield 18.96%
Maximum yield p.a. 13.03%
Sideways yield 18.96%
Sideways yield p.a. 13.03%

market maker quality Date: -

Average Spread -
Last Best Bid Price - %
Last Best Ask Price - %
Last Best Bid Volume 0
Last Best Ask Volume 0
Average Buy Volume 0
Average Sell Volume 0
Average Buy Value 0 USD
Average Sell Value 0 USD
Spreads Availability Ratio -
Quote Availability -

Underlyings

Name Pfizer Inc. Eli Lilly & Co. Johnson & Johnson
ISIN US7170811035 US5324571083 US4781601046
Price 21.78 EUR 890.00 CHF 209.90 EUR
Date 24/06/26 09:16 22/06/26 15:42 24/06/26 09:14
Cap 25.71 USD 1,104.34 USD 207.56 USD
Distance to Cap -0.820001 2.63998 27.48
Distance to Cap in % -3.29% 0.24% 11.69%
Is Cap Level reached No No No
Barrier 12.855 USD 552.17 USD 103.78 USD
Distance to Barrier 11.86 555.78 135.39
Distance to Barrier in % 47.99% 50.16% 56.61%
Is Barrier reached No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.